Century Therapeutics Stock Price on April 16, 2024

IPSC Stock  USD 1.10  0.05  4.76%   
If you're considering investing in Century Stock, it is important to understand the factors that can impact its price. As of today, the current price of Century Therapeutics stands at 1.10, as last reported on the 22nd of December, with the highest price reaching 1.12 and the lowest price hitting 1.05 during the day. Century Therapeutics secures Sharpe Ratio (or Efficiency) of -0.074, which signifies that the company had a -0.074% return per unit of risk over the last 3 months. Century Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Century Therapeutics' Standard Deviation of 5.3, mean deviation of 4.03, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide.
  
Century Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.074

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIPSC

Estimated Market Risk

 5.3
  actual daily
47
53% of assets are more volatile

Expected Return

 -0.39
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Century Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Century Therapeutics by adding Century Therapeutics to a well-diversified portfolio.

Century Therapeutics Valuation on April 16, 2024

It is possible to determine the worth of Century Therapeutics on a given historical date. On April 16, 2024 Century was worth 3.63 at the beginning of the trading date compared to the closed value of 3.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Century Therapeutics stock. Still, in general, we apply an absolute valuation method to find Century Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Century Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Century Therapeutics' related companies.
 Open High Low Close Volume
  3.92    3.99    3.63    3.67    42,136  
04/16/2024
  3.63    3.63    2.99    3.14    320,558  
  3.21    3.22    2.82    2.84    179,248  
Backtest Century Therapeutics  |  Century Therapeutics History  |  Century Therapeutics Valuation   PreviousNext  
Open Value
3.63
3.14
Closing Value
19.52
Upside

Century Therapeutics Trading Date Momentum on April 16, 2024

On April 17 2024 Century Therapeutics was traded for  2.84  at the closing time. The top price for the day was 3.22  and the lowest listed price was  2.82 . The trading volume for the day was 179.2 K. The trading history from April 17, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 9.55% . The overall trading delta against the current closing price is 2.55% .

Century Therapeutics Fundamentals Correlations and Trends

By evaluating Century Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Century Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Century financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Century Therapeutics Stock history

Century Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Century is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Century Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Century Therapeutics stock prices may prove useful in developing a viable investing in Century Therapeutics
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania. Century Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 170 people.

Century Therapeutics Stock Technical Analysis

Century Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Century Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Century Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Century Therapeutics Period Price Range

Low
December 22, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Century Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Century Therapeutics December 22, 2024 Market Strength

Market strength indicators help investors to evaluate how Century Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Century Therapeutics shares will generate the highest return on investment. By undertsting and applying Century Therapeutics stock market strength indicators, traders can identify Century Therapeutics entry and exit signals to maximize returns

Century Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Century Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Century Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Century to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Century Stock analysis

When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data